2025 · 3rd Quarter (July 1 - Sep 30)

EVONIK CORPORATION

Filed by EVONIK CORPORATION.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: EVONIK CORPORATION
Client: EVONIK CORPORATION
Filing UUID: 051c867a-e26f-4742-b240-156342b0927f
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

CHM · Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

ENV · Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Literal federal measure citations: S.623, H.R.1415

BUD · Budget/Appropriations

FY26 appropriations actions H.R. 4 - Rescissions Act of 2025 - (PL 119-28) H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package (PL 119-21)

Literal federal measure citations: H.R. 4, H.R. 1

TAX · Taxation/Internal Revenue Code

General issues related to corporate tax S.615/H.R.640 - Chemical Tax Repeal Act H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package, Section 899 (PL 119-21)

Literal federal measure citations: S.615, H.R.640, H.R. 1

TRD · Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

RRR · Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

TAR · Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.